Garuda Aerospace Pre-IPO Analysis — Should You Invest? (2025)

Garuda Aerospace is India's largest drone company and one of the most talked-about pre-IPO opportunities in 2025. With a DRHP filed and IPO targeted for December 2026, the question every investor is asking is: should I buy now — and at what price?

What is Garuda Aerospace?

Garuda Aerospace is India's largest drone company by fleet size — with over 400 drones, 500+ certified pilots, and operations across 84 cities. Their clients include Tata, Adani, Reliance, DRDO, and ISRO. They hold approximately 55% market share in precision agricultural drones.

The company has been profitable for 4 consecutive years — rare among drone startups globally. FY25 revenue: ₹123.5 Cr.

The IPO Story — Why It Matters

In April 2026, Garuda filed a DRHP (Draft Red Herring Prospectus) with SEBI — the formal step that initiates the IPO process. Target listing: December 2026 on NSE/BSE.

The IPO target valuation is ₹4,000–5,000 Cr. The current unlisted market cap at ₹440/share is approximately ₹2,200 Cr. That gap is your potential upside if the IPO happens at target valuation.

MS Dhoni Brand Association — Real or Marketing?

MS Dhoni is a brand investor in Garuda Aerospace — not a strategic investor or board member. His association provides brand value, especially for agricultural drone sales to rural markets where his name carries significant weight. It is a real association but should not be the primary reason to invest.

Business Strengths

• DRHP filed: This is a legally binding process — harder to walk back than an announcement
• 4 profitable years: Proves business model viability — rare in drone companies
• 55% agri drone share: PM Kisan Drone scheme is driving massive government demand
• Diversified clients: Not dependent on one customer or sector
• Export licence: US, Australia, Middle East approvals in place
• Airbus partnership: Flexrotor deal signed March 2026

Key Risks — Read Before Investing

• Chinese component issue: In Sep 2024, Ministry of Defence flagged potential Chinese components in Garuda drones. Company is working to prove compliance. This could affect government contracts.
• Revenue growth slowed: FY25 grew only 12% vs 134% in FY24. Investors expect acceleration before IPO.
• High receivables: ₹114.8 Cr in receivables vs ₹123.5 Cr revenue suggests collection challenges.
• IPO pricing: At ₹4,000 Cr valuation, the P/S ratio is ~32x — aggressive for a drone company with these margins.
• IPO timeline risk: December 2026 is a target, not a guarantee. SEBI approval, market conditions could delay it.

Who Should Invest?

Garuda Aerospace is suitable for investors who:

• Have a 2–4 year investment horizon
• Can accept the risk of IPO delay or price disappointment
• Want exposure to India's drone sector before it matures
• Are not putting more than 5% of their total portfolio in any single unlisted share

It is not suitable for investors who need liquidity within 1–2 years or those who cannot stomach 30–50% downside scenarios.

Our Verdict

Garuda Aerospace is the lowest-risk unlisted share among our current recommendations — specifically because the DRHP creates a hard exit mechanism. You know roughly when you can exit and at what range. The Chinese component issue is the biggest variable to monitor. If resolved, the IPO thesis strengthens significantly.

Position sizing suggestion: 5–8% of your unlisted portfolio, not your total investment portfolio.